MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemiaBernhard Gentner, Florian Kuchenbauer, Su Ming Sun et al.|Experimental Hematology|2015Cited by 34
Identification of Prognostic Immunophenotypes at First Diagnosis in Patients with Acute Myeloid Leukemia (AML) By a Standardized Multicolor Flow Cytometry (MFC) Panel Originally Designed to Detect Measurable Residual Disease (MRD) at Follow-upMaximilian Alexander Röhnert, Uta Oelschlägel, Malte von Bonin et al.|Blood|2020Cited by 2
Defining minimal residual disease by flow cytometry in acute myeloid leukemia: the HARMONIZE initiativeVeit Bücklein, Malte von Bonin, S. Krause et al.|Unknown|2017Cited by 0